FIELD: medicine, virology, vaccines. SUBSTANCE: invention relates to methods of preparing concentrated virionic antiherpetic vaccines. Herpex simplex viruses of type 1 and 2 are cultured on green monkey kidney cell monolayer showing the sensitivity to the above indicated viruses. After adsorption of viruses on cells the infected cells are incubated in the supporting medium. Viruses are released from cells by the freezing-thawing cycle. Viruses are inactivated by gamma-radiation, for example, by cobalt-60. The suspension of viruses formed after separation of disrupted cell residues by low-speed centrifugation is purified and concentrated by filtration through membranes (pore diameter is 0.07 mcm). Invention proposes the medicinal form of vaccine as suppositorium containing vaccine, butyrum-cacao, hyaluronic acid, α-tocopherol, L-ascorbic acid and α2-interferon. EFFECT: broadened arsenal of agents used for control of viral infection. 5 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARATION OF VIRION HERPETIC VACCINE | 1991 |
|
RU2014084C1 |
PHARMACEUTICAL COMPOSITION FOR PRODUCING ANTIHERPETIC MIXED VACCINE AND BASED DOSAGE FORM | 2014 |
|
RU2552341C1 |
COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
PHARMACEUTICAL ANTI-HERPETIC COMPOSITION AND METHOD FOR OBTAINING MEDICINAL FORM UPON ITS BASIS | 2003 |
|
RU2264819C2 |
IMPROVED MEDICINAL FORM OF INTERFERON INDUCTOR | 1998 |
|
RU2162687C2 |
PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
IMPROVED MEDICINAL FORM OF HUMAN INTERFERON: SUPPOSITORY | 1997 |
|
RU2148988C1 |
PERORALLY, RECTALLY OR INTRAVAGINALLY INJECTED COMPOSITION CONTAINING ALIVE BACTERIA | 2000 |
|
RU2182008C1 |
COMPOSITION FOR PREVENTION OF DISEASES CAUSED BY CMV INFECTION | 2015 |
|
RU2616245C2 |
USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
Authors
Dates
1999-12-20—Published
1997-06-20—Filed